Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Pre-Market Session

 

Gainers

  • Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4 million.
  • Longeveron (NASDAQ:LGVN) stock rose 13.04% to $15.6. The market value of their outstanding shares is at $326.2 million.
  • Cidara Therapeutics (NASDAQ:CDTX) shares rose 11.44% to $0.93. The company's market cap stands at $63.2 million.
  • PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares moved upwards by 10.6% to $1.46. The market value of their outstanding shares is at $71.0 million.
  • Genetron Holdings (NASDAQ:GTH) stock rose 9.58% to $2.4. The market value of their outstanding shares is at $213.2 million. The company's, Q4 earnings came out 3 days ago.
  • BeyondSpring (NASDAQ:BYSI) stock rose 9.09% to $2.4. The company's market cap stands at $93.9 million.

 

Losers

  • SELLAS Life Sciences Gr (NASDAQ:SLS) shares decreased by 37.9% to $4.15 during Friday's pre-market session. The market value of their outstanding shares is at $65.9 million.
  • ARCA biopharma (NASDAQ:ABIO) shares fell 22.18% to $1.79. The company's market cap stands at $25.7 million.
  • Spero Therapeutics (NASDAQ:SPRO) shares declined by 21.38% to $6.84. The market value of their outstanding shares is at $221.0 million. As per the news, the Q4 earnings report came out yesterday.
  • 4d pharma (NASDAQ:LBPS) stock decreased by 11.6% to $4.27. The market value of their outstanding shares is at $96.2 million. As per the news, the FY earnings report came out yesterday.
  • Blue Water Vaccines (NASDAQ:BWV) stock fell 7.97% to $52.0. The market value of their outstanding shares is at $574.5 million.
  • Cumberland (NASDAQ:CPIX) shares decreased by 7.81% to $2.6. The company's market cap stands at $38.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.